title: [Prevention of contrast-induced nephropathy in the context of evidence-based medicine].
abstract: The paper considers the mechanisms of development of contrast-induced nephropathy in the use of iodinated radiopaque contrast agents (RCAs), as well as the criteria of their assessment. It gives different existing recommendations for prevention of the nephrotoxic effects of RCAs.
authors.forename: P M
authors.initials: PM
authors.lastname: Baryshev
authors.forename: Iu K
authors.initials: IuK
authors.lastname: Napolov
authors.forename: I Z
authors.initials: IZ
authors.lastname: Korobkova
authors.forename: N L
authors.initials: NL
authors.lastname: Shimanovskiĭ
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced / Q000175:diagnosis / Q000517:prevention & control; D015415:Biomarkers / Q000652:urine; D003287:Contrast Media / Q000009:adverse effects / Q000145:classification; D019317:Evidence-Based Medicine; D000072596:Hepatitis A Virus Cellular Receptor 1; D006801:Humans; D020382:Interleukin-18 / Q000652:urine; D007457:Iodine Radioisotopes / Q000009:adverse effects / Q000145:classification; D007677:Kidney Function Tests / Q000379:methods; D008562:Membrane Glycoproteins / Q000652:urine; D027701:Organic Cation Transport Proteins / Q000652:urine; D011991:Receptors, Virus; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D015415:Biomarkers; D003287:Contrast Media; C491143:HAVCR1 protein, human; D000072596:Hepatitis A Virus Cellular Receptor 1; D020382:Interleukin-18; D007457:Iodine Radioisotopes; D008562:Membrane Glycoproteins; D027701:Organic Cation Transport Proteins; D011991:Receptors, Virus; C518841:SLC22A17 protein, human